The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dr Somnath Chatterjee
SURAKSHA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dr. Somnath Chatterjee, Promoter, Chairman & Joint Managing Director of Suraksha Diagnostic Ltd, bought 7,800 equity shares through an open market purchase on 18 August 2025. His stake in the company increased marginally from 5.082% (26,46,968 shares) to 5.097% (26,54,768 shares), a rise of just 0.015%. The disclosure was filed under Regulation 29(2) of SEBI's Takeover Regulations. The company's total paid-up equity capital stands at 5,20,80,758 shares of Rs 2 each.
The acquisition is very small (just 7,800 shares) and signals promoter confidence, but is too tiny to materially affect shareholding or stock price. Existing shareholders should note the promoter continues to hold well below majority levels at around 5.1%.